Insulin Aspart Injection + Octreotide Interaction
Majorinteraction on record
Description
Somatostatin analog that may increase the risk of hypoglycemia. Dose adjustment and increased glucose monitoring may be required.
Mechanism
Increased risk of hypoglycemia
Source: NLP:insulin aspart